Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00359970Phase 4Completed
Phase 4, randomised, double-blind trial of loperamide in traveler's diarrhea (TD) (3 arms), sponsored by UTHealth Houston. Primary endpoint: Hours from beginning treatment to passage of last unformed stool at 4 days. Started Jun 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00359970.